BridgeBio Pharma, Inc. (BBIO)
67.37
-0.24
(-0.35%)
USD |
NASDAQ |
Jun 08, 16:00
67.37
0.00 (0.00%)
After-Hours: 18:55
BridgeBio Pharma Market Cap : 13.18B for June 8, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Pfizer Inc. | 146.01B |
| Alnylam Pharmaceuticals, Inc. | 38.99B |
| Ionis Pharmaceuticals, Inc. | 12.20B |
| BioMarin Pharmaceutical, Inc. | 10.94B |
| Cytokinetics, Inc. | 8.433B |
Market Cap Related Metrics
| PS Ratio | 22.38 |
| PEG Ratio | -2.952 |
| Price | 67.37 |
| Earnings Yield | -5.56% |
| PEGY Ratio | -2.952 |